Many people who have had a cancer diagnosis or have a family member or friend who has been affected constantly look for new treatments with fewer side effects. It is a debilitating and frightening disease that impacts every phase of a patients’ life physically and emotionally. Researchers are always looking for the latest techniques to make treatments easier while trying to cure and eradicate the cancer cells. Oncotarget is also available on Dove Press.
Oncotarget.com is a resource for researchers and oncologists to share ideas and treatment results to help each other give the best options for their patients. Articles are submitted for access to the latest ideas and studies and are encouraged by the founders. It was started in 2010 by editors-in-chief Mikhail Blagosklonny and Andrei V. Gudkov of the Roswell Park Cancer Institute. It is a peer reviewed, open access medical journal covering all aspects of cancer care and research published by Impact Journal.
The goal is to help authors who wish to submit articles increase the impact of their research and provide their studies and information to all researchers and oncology professionals. Authors who wish to publish papers can read the guidelines on the Oncotarget.com website and submit their works to be included in journals published weekly at Impact Journal. Many who have had their work turned away by other sources have found success with Oncotarget that has been rated #1 in total documents in 2015 among all journals in Oncology.
That is an outstanding result for a company still considered new in the industry. The ability to access studies, reports and techniques from other professionals makes it easier for clinicians to find the latest in care advice for patients and to realize their goals to:
- Maximize the impact of research with insightful reviews
- Allow exceptional discoveries to be shared more quickly
- Eliminate borders between specialties
- Link different fields of biomedical science
- Foster applications of basic and clinical science to fight disease
- Life without disease is the ultimate goal
The top 100 Oncotarget publications in the media have been rated by Altmetric Attention score.
Follow them on Twitter and Facebook. Clinicians can subscribe to the publications and receive notice of the latest submissions, review their website for specific topics of interest and even submit their own publications.
Oncotarget’s impact for the studies and cures of cancers has made its mark and wants to share their research with as many people as possible. Take advantage of their resources today to stay up to date on the latest news and provide the best care for your patients. Learn more about Oncotarget journal at Bioxbio.com.